| A study of variations in the reported haemophilia A prevalence around the world JS Stonebraker, PHB BOLTON‐MAGGS, J Michael Soucie, I Walker, ... Haemophilia 16 (1), 20-32, 2010 | 387 | 2010 |
| Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries A Iorio, JS Stonebraker, H Chambost, M Makris, D Coffin, C Herr, ... Annals of internal medicine 171 (8), 540-546, 2019 | 346 | 2019 |
| A study of variations in the reported haemophilia B prevalence around the world JS Stonebraker, PHB BOLTON‐MAGGS, J Michael Soucie, I Walker, ... Haemophilia 18 (3), e91-e94, 2012 | 147 | 2012 |
| A study of reported factor VIII use around the world JS Stonebraker, M Brooker, RE Amand, A Farrugia, A Srivastava Haemophilia 16 (1), 33-46, 2010 | 93 | 2010 |
| Data and Demographics Committee of the World Federation of Hemophilia. Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach … A Iorio, JS Stonebraker, H Chambost, M Makris, D Coffin, C Herr, ... Ann Intern Med 171 (8), 540-546, 2019 | 86 | 2019 |
| The world federation of hemophilia annual global survey 1999‐2018 JS Stonebraker, PHB Bolton‐Maggs, M Brooker, B Evatt, A Iorio, M Makris, ... Haemophilia 26 (4), 591-600, 2020 | 83 | 2020 |
| How Bayer makes decisions to develop new drugs JS Stonebraker Interfaces 32 (6), 77-90, 2002 | 65 | 2002 |
| The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia MW Skinner, C Chai-Adisaksopha, R Curtis, N Frick, M Nichol, D Noone, ... Pilot and Feasibility Studies 4, 1-10, 2018 | 52 | 2018 |
| Impact factor as a metric to assess journals where OM research is published JS Stonebraker, E Gil, CW Kirkwood, RB Handfield Journal of Operations Management 30 (1-2), 24-43, 2012 | 39 | 2012 |
| Modeling primary immunodeficiency disease epidemiology and its treatment to estimate latent therapeutic demand for immunoglobulin JS Stonebraker, A Farrugia, B Gathmann, ESID Registry Working Party, ... Journal of clinical immunology 34, 233-244, 2014 | 31 | 2014 |
| A study of reported factor IX use around the world JS Stonebraker, PHB BOLTON‐MAGGS, M Brooker, A Farrugia, ... Haemophilia 17 (3), 446-455, 2011 | 27 | 2011 |
| Non‐severe haemophilia: is it benign?–insights from the PROBE study C Chai‐Adisaksopha, D Noone, R Curtis, N Frick, MB Nichol, F Germini, ... Haemophilia 27, 17-24, 2021 | 26 | 2021 |
| Psychometric properties of the patient reported outcomes, burdens and experiences (PROBE) questionnaire C Chai-Adisaksopha, MW Skinner, R Curtis, N Frick, MB Nichol, D Noone, ... BMJ open 8 (8), e021900, 2018 | 25 | 2018 |
| Modelling haemophilia epidemiology and treatment modalities to estimate the unconstrained factor VIII demand JS Stonebraker, RE Amand, MV Bauman, AJ Nagle, PJ Larson Haemophilia 10 (1), 18-26, 2004 | 25 | 2004 |
| A country‐by‐country comparison of FVIII concentrate consumption and economic capacity for the global haemophilia community JS Stonebraker, RE Amand, AJ Nagle Haemophilia 9 (3), 245-250, 2003 | 24 | 2003 |
| Formulating and solving sequential decision analysis models with continuous variables JS Stonebraker, CW Kirkwood IEEE Transactions on Engineering Management 44 (1), 43-53, 1997 | 24 | 1997 |
| Test‐retest properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire and its constituent domains C Chai‐Adisaksopha, MW Skinner, R Curtis, N Frick, MB Nichol, D Noone, ... Haemophilia 25 (1), 75-83, 2019 | 20 | 2019 |
| New York power authority uses decision analysis to schedule refueling of its Indian point 3 nuclear power plant DJ Dunning, S Lockfort, QE Ross, PC Beccue, JS Stonebraker Interfaces 31 (5), 121-135, 2001 | 20 | 2001 |
| Exploring regional variations in the cross‐cultural, international implementation of the Patient Reported Outcomes Burdens and Experience (PROBE) study C Chai‐Adisaksopha, MW Skinner, R Curtis, N Frick, MB Nichol, D Noone, ... Haemophilia 25 (3), 365-372, 2019 | 15 | 2019 |
| OR practice—modeling potential demand for supply-constrained drugs: A new hemophilia drug at Bayer biological products JS Stonebraker, DL Keefer Operations research 57 (1), 19-31, 2009 | 13 | 2009 |
